[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":613,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":20.08,"TPM_sd":21.72,"TPM_min":0.93,"TPM_25th_percentile":5.52,"TPM_median":11.8,"TPM_75th_percentile":26.46,"TPM_max":180.54},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":210,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.29,"TPM_sd":16.25,"TPM_min":0,"TPM_25th_percentile":5.45,"TPM_median":10.2,"TPM_75th_percentile":17.75,"TPM_max":149.86},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 53)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":53,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.51,"TPM_sd":16.16,"TPM_min":2.37,"TPM_25th_percentile":5.92,"TPM_median":7.61,"TPM_75th_percentile":8.85,"TPM_max":118.18},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":59,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.63,"TPM_sd":16.18,"TPM_min":2.63,"TPM_25th_percentile":4.98,"TPM_median":6.58,"TPM_75th_percentile":9.45,"TPM_max":117.84},{"x_label":"Central neurocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Central neurocytoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000856","MONDO":"MONDO_0019134","GTEx_tissue_subgroup_UBERON":"","TPM_mean":26.79,"TPM_sd":29.89,"TPM_min":8.94,"TPM_25th_percentile":9.54,"TPM_median":10.14,"TPM_75th_percentile":35.72,"TPM_max":61.3},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.64,"TPM_sd":2.51,"TPM_min":3.45,"TPM_25th_percentile":3.89,"TPM_median":4.89,"TPM_75th_percentile":6.19,"TPM_max":11.51},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":15,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":20.84,"TPM_sd":32.22,"TPM_min":1.91,"TPM_25th_percentile":4.36,"TPM_median":6.09,"TPM_75th_percentile":18.13,"TPM_max":97.97},{"x_label":"Choroid plexus papilloma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 26)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":26,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus papilloma","GTEx_tissue_subgroup":"","EFO":"EFO_1000177","MONDO":"MONDO_0009837","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.68,"TPM_sd":2.89,"TPM_min":2.78,"TPM_25th_percentile":5.78,"TPM_median":8.14,"TPM_75th_percentile":9.33,"TPM_max":11.87},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 18)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":18,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":20.48,"TPM_sd":21.93,"TPM_min":4.1,"TPM_25th_percentile":5.47,"TPM_median":9.71,"TPM_75th_percentile":30.77,"TPM_max":80.99},{"x_label":"CNS neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0006130","GTEx_tissue_subgroup_UBERON":"","TPM_mean":33.62,"TPM_sd":47.33,"TPM_min":5.23,"TPM_25th_percentile":6.3,"TPM_median":7.38,"TPM_75th_percentile":47.82,"TPM_max":88.26},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 22)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":22,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.29,"TPM_sd":4.68,"TPM_min":2.01,"TPM_25th_percentile":3.59,"TPM_median":4.88,"TPM_75th_percentile":6.71,"TPM_max":23.26},{"x_label":"Desmoplastic infantile astrocytoma and ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Desmoplastic infantile astrocytoma and ganglioglioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0022963","MONDO":"MONDO_0022963","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.92,"TPM_sd":2.41,"TPM_min":4.12,"TPM_25th_percentile":4.54,"TPM_median":4.97,"TPM_75th_percentile":6.81,"TPM_max":8.66},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.85,"TPM_sd":2.19,"TPM_min":2.31,"TPM_25th_percentile":5.12,"TPM_median":5.98,"TPM_75th_percentile":6.77,"TPM_max":10.2},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":164,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":15.23,"TPM_sd":17.29,"TPM_min":0.86,"TPM_25th_percentile":5.48,"TPM_median":8.15,"TPM_75th_percentile":17.25,"TPM_max":86.15},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":39,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.35,"TPM_sd":4.31,"TPM_min":2.95,"TPM_25th_percentile":5.81,"TPM_median":9.41,"TPM_75th_percentile":11.15,"TPM_max":23},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.76,"TPM_sd":5.16,"TPM_min":6.05,"TPM_25th_percentile":11.18,"TPM_median":12.41,"TPM_75th_percentile":13.13,"TPM_max":23.96},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":163,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.76,"TPM_sd":5.85,"TPM_min":0.36,"TPM_25th_percentile":5.29,"TPM_median":6.63,"TPM_75th_percentile":8.61,"TPM_max":58.85},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.72,"TPM_sd":4.14,"TPM_min":2.78,"TPM_25th_percentile":7.02,"TPM_median":9.17,"TPM_75th_percentile":11.6,"TPM_max":18.7},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":80,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.62,"TPM_sd":4.55,"TPM_min":0.95,"TPM_25th_percentile":5.42,"TPM_median":8.04,"TPM_75th_percentile":11.29,"TPM_max":25.97},{"x_label":"Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 46)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":46,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":17.81,"TPM_sd":10.48,"TPM_min":1.27,"TPM_25th_percentile":10.54,"TPM_median":16.24,"TPM_75th_percentile":20.01,"TPM_max":53.14},{"x_label":"Ganglioneuroma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioneuroma","GTEx_tissue_subgroup":"","EFO":"EFO_0000500","MONDO":"MONDO_0005033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.99,"TPM_sd":2.68,"TPM_min":3.25,"TPM_25th_percentile":4.69,"TPM_median":6.12,"TPM_75th_percentile":7.36,"TPM_max":8.6},{"x_label":"Germinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Germinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.03,"TPM_sd":7.18,"TPM_min":3.3,"TPM_25th_percentile":3.71,"TPM_median":5.69,"TPM_75th_percentile":13.25,"TPM_max":25.33},{"x_label":"Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":25,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor NOS","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":16.66,"TPM_sd":23.09,"TPM_min":2.21,"TPM_25th_percentile":5.82,"TPM_median":8.09,"TPM_75th_percentile":12.8,"TPM_max":86.91},{"x_label":"Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Hemangioblastoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016748","MONDO":"MONDO_0016748","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.15,"TPM_sd":2.43,"TPM_min":5.76,"TPM_25th_percentile":5.96,"TPM_median":6.11,"TPM_75th_percentile":6.46,"TPM_max":11.47},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":17.62,"TPM_sd":16.27,"TPM_min":2.2,"TPM_25th_percentile":6.5,"TPM_median":10.38,"TPM_75th_percentile":25.03,"TPM_max":81.59},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.56,"TPM_sd":5.58,"TPM_min":0.95,"TPM_25th_percentile":4.6,"TPM_median":7.3,"TPM_75th_percentile":10.46,"TPM_max":25.74},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.53,"TPM_sd":1.96,"TPM_min":2.75,"TPM_25th_percentile":5.57,"TPM_median":6.65,"TPM_75th_percentile":7.88,"TPM_max":9.18},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 400)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":400,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.9,"TPM_sd":6.73,"TPM_min":1.27,"TPM_25th_percentile":5.93,"TPM_median":7.77,"TPM_75th_percentile":10.23,"TPM_max":88.25},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":25,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.49,"TPM_sd":4.58,"TPM_min":2.83,"TPM_25th_percentile":5.26,"TPM_median":6.5,"TPM_75th_percentile":8.12,"TPM_max":24.92},{"x_label":"Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Malignant peripheral nerve sheath tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0000760","MONDO":"MONDO_0017827","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.24,"TPM_sd":2.72,"TPM_min":3.22,"TPM_25th_percentile":4.27,"TPM_median":5.97,"TPM_75th_percentile":7.45,"TPM_max":10.6},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":237,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":17.96,"TPM_sd":26.28,"TPM_min":1.59,"TPM_25th_percentile":8.74,"TPM_median":11.89,"TPM_75th_percentile":17.18,"TPM_max":241.56},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":42,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7,"TPM_sd":4.92,"TPM_min":0.3,"TPM_25th_percentile":4.85,"TPM_median":6.01,"TPM_75th_percentile":7.98,"TPM_max":33.84},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 317)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":317,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":26.07,"TPM_sd":16.82,"TPM_min":2.63,"TPM_25th_percentile":12.6,"TPM_median":21.68,"TPM_75th_percentile":37.21,"TPM_max":101.37},{"x_label":"Neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.9,"TPM_sd":3.45,"TPM_min":3.34,"TPM_25th_percentile":4.35,"TPM_median":6.13,"TPM_75th_percentile":8.75,"TPM_max":12.4},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":137,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.91,"TPM_sd":5.25,"TPM_min":2.63,"TPM_25th_percentile":9.29,"TPM_median":12.3,"TPM_75th_percentile":16.23,"TPM_max":26.87},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":20,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.25,"TPM_sd":2.76,"TPM_min":1.44,"TPM_25th_percentile":3.14,"TPM_median":4.83,"TPM_75th_percentile":6.46,"TPM_max":12.81},{"x_label":"Non-germinomatous germ cell tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Non-germinomatous germ cell tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.05,"TPM_sd":11.31,"TPM_min":2.98,"TPM_25th_percentile":3.03,"TPM_median":6.25,"TPM_75th_percentile":13.08,"TPM_max":29.89},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":30,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.15,"TPM_sd":6,"TPM_min":4.79,"TPM_25th_percentile":8.93,"TPM_median":10.29,"TPM_75th_percentile":13.56,"TPM_max":36.92},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":31.57,"TPM_sd":39.46,"TPM_min":3.69,"TPM_25th_percentile":6.7,"TPM_median":11.75,"TPM_75th_percentile":21.61,"TPM_max":102.03},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.73,"TPM_sd":2.25,"TPM_min":1.93,"TPM_25th_percentile":2.78,"TPM_median":4.04,"TPM_75th_percentile":6.65,"TPM_max":8.45},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":27,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.31,"TPM_sd":2.55,"TPM_min":2.17,"TPM_25th_percentile":4.52,"TPM_median":5.44,"TPM_75th_percentile":8.75,"TPM_max":11.28},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.56,"TPM_sd":6.18,"TPM_min":0.83,"TPM_25th_percentile":3,"TPM_median":5.44,"TPM_75th_percentile":12.34,"TPM_max":19.09},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.38,"TPM_sd":5.31,"TPM_min":2.45,"TPM_25th_percentile":8.72,"TPM_median":11.69,"TPM_75th_percentile":15.08,"TPM_max":34.82},{"x_label":"Colon Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 289)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":289,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Colon Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1001949","MONDO":"MONDO_0002271","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.94,"TPM_sd":3.45,"TPM_min":1.3,"TPM_25th_percentile":2.65,"TPM_median":3.27,"TPM_75th_percentile":4.23,"TPM_max":35.43},{"x_label":"Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 165)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":165,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Glioblastoma Multiforme","GTEx_tissue_subgroup":"","EFO":"EFO_0000519","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.2,"TPM_sd":1.67,"TPM_min":0.85,"TPM_25th_percentile":3.02,"TPM_median":4.05,"TPM_75th_percentile":4.9,"TPM_max":12.09},{"x_label":"Hepatocellular Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 371)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":371,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Hepatocellular Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000182","MONDO":"MONDO_0007256","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.17,"TPM_sd":1.21,"TPM_min":0.44,"TPM_25th_percentile":1.29,"TPM_median":1.9,"TPM_75th_percentile":2.75,"TPM_max":8.36},{"x_label":"Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 521)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":521,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.57,"TPM_sd":1.98,"TPM_min":1.41,"TPM_25th_percentile":4.14,"TPM_median":5.34,"TPM_75th_percentile":6.69,"TPM_max":13.23},{"x_label":"Lung Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 512)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":512,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Lung Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000571","MONDO":"MONDO_0005061","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.24,"TPM_sd":4.08,"TPM_min":0.7,"TPM_25th_percentile":3.44,"TPM_median":4.36,"TPM_75th_percentile":6.01,"TPM_max":48.05},{"x_label":"Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 378)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":378,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Ovarian Serous Cystadenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000043","MONDO":"MONDO_0006046","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.23,"TPM_sd":1.58,"TPM_min":1.1,"TPM_25th_percentile":3.18,"TPM_median":4.04,"TPM_75th_percentile":5.01,"TPM_max":11.23},{"x_label":"Rectum Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 93)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":93,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Rectum Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0005631","MONDO":"MONDO_0002169","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.63,"TPM_sd":1.17,"TPM_min":0.92,"TPM_25th_percentile":2.81,"TPM_median":3.44,"TPM_75th_percentile":4.33,"TPM_max":6.54},{"x_label":"Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 261)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":261,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.43,"TPM_sd":2.18,"TPM_min":1.08,"TPM_25th_percentile":2.91,"TPM_median":4.12,"TPM_75th_percentile":5.45,"TPM_max":19.22},{"x_label":"Uterine Corpus Endometrial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 179)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":179,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Uterine Corpus Endometrial Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0007532","MONDO":"MONDO_0000553","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.41,"TPM_sd":4.37,"TPM_min":0.58,"TPM_25th_percentile":2.7,"TPM_median":3.8,"TPM_75th_percentile":4.96,"TPM_max":44.36}]